Esco Lifesciences Group, a Singapore firm that pivoted from washing lab gowns to making high-tech equipment.
SINGAPORE: Esco Lifesciences Group, a Singapore firm that pivoted from washing lab gowns to making high-tech equipment, raised $200 million from some of the world’s biggest health-care investors, paving the way for a possible listing in Hong Kong this year.
The funding round led by Danish investment giant Novo Holdings AS and U.S. investor Vivo Capital also included Chinese sovereign wealth fund China Investment Corp., according to a statement from Esco. Other new backers include Singapore’s GIC Pte., with the fundraising giving the company a valuation of $800 million, according to people familiar with the matter, who asked not to be identified as the details aren’t public.
Limited time offer:
Just RM5 per month.
